CCM
GRCL

CloudAlpha Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

CloudAlpha Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-75,000
Closed -$1.04M – 25
2021
Q3 		$1.04M Sell
75,000
-215,000
-74% -$2.54M 0.31% 12
2021
Q2 		$3.77M Buy
+290,000
New +$3.88M 0.45% 24

Other funds holding GRCL

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CloudAlpha Capital Management's GRCL Position: Q4 2021 in Review

CloudAlpha Capital Management sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q4 2021, closing a stake of 75,000 shares — an estimated $1.04M sold.

CloudAlpha Capital Management first reported a position in GRCL in Q2 2021 and held it in 2 quarters. The position peaked at $3.77M in Q2 2021. 35 funds tracked by Wall St. Rank hold GRCL as of Q4 2021.

  • CloudAlpha Capital Management reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • CloudAlpha Capital Management sold 75,000 Gracell Biotechnologies Inc. American Depositary Shares shares in Q4 2021, an estimated $1.04M.
  • CloudAlpha Capital Management first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q2 2021 and held it in 2 quarters.
  • CloudAlpha Capital Management's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $3.77M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q4 2021.

Based on CloudAlpha Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.